NM_018129.4:c.448_451delCCTG
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018129.4(PNPO):c.448_451delCCTG(p.Pro150ArgfsTer27) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,726 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P150P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_018129.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- pyridoxal phosphate-responsive seizuresInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152172Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251026 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461554Hom.: 0 AF XY: 0.00000275 AC XY: 2AN XY: 727060 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Pyridoxal phosphate-responsive seizures Pathogenic:2
- -
This sequence change creates a premature translational stop signal (p.Pro150Argfs*27) in the PNPO gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PNPO are known to be pathogenic (PMID: 15772097, 24645144). This variant is present in population databases (rs775105142, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with clinical features of pyridoxal 5'-phosphate-dependent epilepsy (PMID: 28349276, 29588952). ClinVar contains an entry for this variant (Variation ID: 206460). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
c.448_451delCCTG: p.Pro150ArgfsX27 in exon 5 in the PNPO gene (NM_018129.3). The normal sequence with the bases that are deleted in braces is: ACTG{CCTG}AGGA. The maternally inherited c.448_451delCCTG mutation in the PNPO gene has not been reported previously as a disease-causing mutation nor as a benign polymorphism, to our knowledge. The c.448_451delCCTG mutation causes a frameshift starting with codon Proline 150, changes this amino acid to a Arginine residue and creates a premature Stop codon at position 27 of the new reading frame, denoted p.Pro150ArgfsX27. This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.448_451delCCTG mutation was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.448_451delCCTG as a disease-causing mutation. This variant has been observed to be maternally inherited The variant is found in PNPO, panel(s). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at